PDF herunterladen
Horm Metab Res 2025; 57(01): 55-66
DOI: 10.1055/a-2458-7088
Original Article: Endocrine Care

Retracted Article: Prediction of the Survival Status, Immunotherapy Response, and Medication of Lung Adenocarcinoma Patients Based on Hypoxia- and Apoptosis-Related Genes

Ziliang Shi
1   Thoracic Surgery, The Affiliated Anyang Tumor Hospital of Henan University of Science and Technology, Anyang, China
,
Zi Sang
1   Thoracic Surgery, The Affiliated Anyang Tumor Hospital of Henan University of Science and Technology, Anyang, China
,
Junmeng Xiao
1   Thoracic Surgery, The Affiliated Anyang Tumor Hospital of Henan University of Science and Technology, Anyang, China
,
Jianbin Hou
1   Thoracic Surgery, The Affiliated Anyang Tumor Hospital of Henan University of Science and Technology, Anyang, China
,
Mingfei Geng
1   Thoracic Surgery, The Affiliated Anyang Tumor Hospital of Henan University of Science and Technology, Anyang, China
› Institutsangaben
› Weitere Informationen
Auch verfügbar auf
  als PDF herunterladen  Lizenzen und Reprints

Dieser Artikel wurde zurückgezogen. Details siehe:

Retraction Note: Prediction of the Survival Status, Immunotherapy Response, and Medication of Lung Adenocarcinoma Patients Based on Hypoxia- and Apoptosis-Related GenesHorm Metab Res 2025; 57(01): e1-e1
DOI: 10.1055/a-2575-5491



Publikationsverlauf

Eingereicht: 24. Mai 2024

Angenommen nach Revision: 23. Oktober 2024

Artikel online veröffentlicht:
22. November 2024

© 2024. Thieme. All rights reserved.

Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany